Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Alton, Eric WFW"'
Autor:
Mitomo, Katsuyuki, Griesenbach, Uta, Inoue, Makoto *, Somerton, Lucinda, Meng, Cuixiang, Akiba, Eiji, Tabata, Toshiaki, Ueda, Yasuji, Frankel, Gad M, Farley, Raymond, Singh, Charanjit, Chan, Mario, Munkonge, Felix, Brum, Andrea, Xenariou, Stefania, Escudero-Garcia, Sara, Hasegawa, Mamoru, Alton, Eric WFW
Publikováno v:
In Molecular Therapy June 2010 18(6):1173-1182
Publikováno v:
Respiratory Research, Vol 1, Iss 2, Pp 78-81 (2000)
Abstract The identification of the cystic fibrosis (CF) gene opened the way for gene therapy. In the ten years since then, proof of principle in vitro and then in animal models in vivo has been followed by numerous clinical studies using both viral a
Externí odkaz:
https://doaj.org/article/1a6a17371af74077a190be3620c8bd0c
Publikováno v:
Thorax; 2024, Vol. 79 Issue: 9 p809-810, 2p
Autor:
Hu Jim, Chow Yu-Hua, Hyde Stephen C, Gill Deborah R, Smith Rbecca L, Painter Hazel, Somerton Luci, Singh Charanjit, Farley Raymond, Garcia Sara, Kitson Chris, Griesenbach Uta, Gray Mike, Edbrooke Mark, Ogilvie Varrie, MacGregor Gordon, Scheule Ronald K, Cheng Seng H, Caplen Natasha J, Alton Eric WFW
Publikováno v:
Respiratory Research, Vol 7, Iss 1, p 26 (2006)
Abstract Background The cationic lipid Genzyme lipid (GL) 67 is the current "gold-standard" for in vivo lung gene transfer. Here, we assessed, if GL67 mediated uptake of siRNAs and asODNs into airway epithelium in vivo. Methods Anti-lacZ and ENaC (ep
Externí odkaz:
https://doaj.org/article/04dfa5f2f34d4da1891b04915a9fe79f
Publikováno v:
In Current Opinion in Pharmacology 2001 1(3):272-278
Autor:
Alton, Eric WFW, Beekman, Jeffery M, Boyd, A Christopher, Brand, June, Carlon, Marianne, Connolly, Mary M, Chan, Mario, Conlon, Sinead, Davidson, Heather E, Davies, Jane C, Davies, Lee A, Dekkers, Johanna F, Doherty, Ann, Gea-Sorli, Sabrina, Gill, Deborah R, Griesenbach, Uta, Hasegawa, Mamoru, Higgins, Tracy E, Hironaka, Takashi, Hyndman, Laura, McLachlan, Gerry, Inoue, Makoto, Hyde, Stephen C, Innes, J Alastair, Maher, Toby M, Moran, Caroline, Meng, Cuixiang, Paul-Smith, Michael C, Pringle, Ian A, Pytel, Kamila M, Rodriguez-Martinez, Andrea, Schmidt, Alexander C, Stevenson, Barbara J, Sumner-Jones, Stephanie G, Toshner, Richard, Tsugumine, Shu, Wasowicz, Marguerite W, Zhu, Jie
Publikováno v:
Alton, E WFW, Beekman, J M, Boyd, A C, Brand, J, Carlon, M S, Connolly, M M, Chan, M, Conlon, S, Davidson, H, Davies, J C, Davies, L A, Dekkers, J F, Doherty, A, Gea-sorli, S, Gill, D R, Griesenbach, U, Hasegawa, M, Higgins, T E, Hironaka, T, Hyndman, L, McLachlan, G, Inoue, M, Hyde, S C, Innes, J A, Maher, T M, Moran, C, Meng, C, Paul-Smith, M C, Pringle, I A, Pytel, K M, Rodriguez-Martinez, A, Schmidt, A C, Stevenson, B, Sumner-Jones, S G, Toshner, R, Tsugumine, S, Wasowicz, M W & Zhu, J 2017, ' Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis ', Thorax, vol. 72, no. 2, pp. 137-147 . https://doi.org/10.1136/thoraxjnl-2016-208406
Thorax
Thorax
We have recently shown that non-viral gene therapy can stabilise the decline of lung function in patients with cystic fibrosis (CF). However, the effect was modest, and more potent gene transfer agents are still required. Fuson protein (F)/Hemaggluti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f6bf734ca182ac101485c3ece68626a2
https://ora.ox.ac.uk/objects/uuid:06e16f3b-e8eb-4ccb-b37f-5e85a5a75530
https://ora.ox.ac.uk/objects/uuid:06e16f3b-e8eb-4ccb-b37f-5e85a5a75530
Autor:
Alton, Eric Wfw, Armstrong, David K, Ashby, Deborah, Bayfield, Katie J, Bilton, Diana, Bloomfield, Emily V, Boyd, A Christopher, Brand, June, Buchan, Ruaridh, Calcedo, Roberto, Carvelli, Paula, Chan, Mario, Cheng, Seng H, Collie, David S, Cunningham, Steve, Davidson, Heather E, Davies, Gwyneth, Davies, Jane C, Davies, Lee A, Dewar, Maria H, Doherty, Ann, Donovan, Jackie, Dwyer, Natalie S, Elgmati, Hala I, Featherstone, Rosanna F, Gavino, Jemyr, Gea-sorli, Sabrina, Geddes, Duncan M, Gibson, James Sr, Gill, Deborah R, Greening, Andrew P, Griesenbach, Uta, Hansell, David M, Harman, Katharine, Higgins, Tracy E, Hodges, Samantha L, Hyde, Stephen C, Hyndman, Laura, Innes, J Alastair, Jacob, Joseph, Jones, Nancy, Keogh, Brian F, Limberis, Maria P, Lloyd-evans, Paul, Maclean, Alan W, Manvell, Michelle C, Mccormick, Dominique, Mcgovern, Michael, Mclachlan, Gerry, Meng, Cuixiang, Montero, M Angeles, Milligan, Hazel, Moyce, Laura J, Murray, Gordon D, Nicholson, Andrew G, Osadolor, Tina, Parra-leiton, Javier, Porteous, David J, Pringle, Ian A, Punch, Emma K, Pytel, Kamila M, Quittner, Alexandra L, Rivellini, Gina, Saunders, Clare J, Scheule, Ronald K, Sheard, Sarah, Simmonds, Nicholas J, Smith, Keith, Smith, Stephen N, Soussi, Najwa, Soussi, Samia, Spearing, Emma J, Stevenson, Barbara J, Sumner-jones, Stephanie G, Turkkila, Minna, Ureta, Rosa P, Waller, Michael D, Wasowicz, Marguerite Y, Wilson, James M, Wolstenholme-hogg, Paul
Publikováno v:
Alton, E W, Armstrong, D K, Ashby, D, Bayfield, K J, Bilton, D, Bloomfield, E V, Boyd, A C, Brand, J, Buchan, R, Calcedo, R, Carvelli, P, Chan, M, Cheng, S H, Collie, D S, Cunningham, S, Davidson, H E, Davies, G, Davies, J C, Davies, L A, Dewar, M H, Doherty, A, Donovan, J, Dwyer, N S, Elgmati, H I, Featherstone, R F, Gavino, J, Gea-sorli, S, Geddes, D M, Gibson, J S, Gill, D R, Greening, A P, Griesenbach, U, Hansell, D M, Harman, K, Higgins, T E, Hodges, S L, Hyde, S C, Hyndman, L, Innes, J A, Jacob, J, Jones, N, Keogh, B F, Limberis, M P, Lloyd-evans, P, Maclean, A W, Manvell, M C, Mccormick, D, Mcgovern, M, Mclachlan, G, Meng, C, Montero, M A, Milligan, H, Moyce, L J, Murray, G D, Nicholson, A G, Osadolor, T, Parra-leiton, J, Porteous, D J, Pringle, I A, Punch, E K, Pytel, K M, Quittner, A L, Rivellini, G, Saunders, C J, Scheule, R K, Sheard, S, Simmonds, N J, Smith, K, Smith, S N, Soussi, N, Soussi, S, Spearing, E J, Stevenson, B J, Sumner-jones, S G, Turkkila, M, Ureta, R P, Waller, M D, Wasowicz, M Y, Wilson, J M & Wolstenholme-hogg, P 2016, A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis . Efficacy and Mechanism Evaluation, no. 5, vol. 3, vol. 3 . https://doi.org/10.3310/eme03050
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3094::652d7f6547305ca5fd120989d6732d40
https://hdl.handle.net/20.500.11820/6cbd29f1-9d74-4a71-a11a-6d87edad87e6
https://hdl.handle.net/20.500.11820/6cbd29f1-9d74-4a71-a11a-6d87edad87e6
Autor:
Alton, Eric WFW1, Geddes, Duncan1
Publikováno v:
Journal of the Royal Society of Medicine (Supplement). Feb1997, Vol. 90 Issue 31, p43-46. 4p.
Autor:
Griesenbach, Uta, Alton, Eric WFW
Publikováno v:
Expert Opinion on Biological Therapy; March 2013, Vol. 13 Issue: 3 p345-360, 16p
Publikováno v:
Gene Therapy. Feb99, Vol. 6 Issue 2, p155. 2p.